IBM shares were downgraded to sell from neutral by a UBS analyst.
Analyst David Vogt also cut his price target on the tech company’s shares to $124 from $136. Vogt mentioned in a research note that near-term risk to fourth-quarter operating estimates and an "elevated valuation" implies that the shares are "vulnerable" over the next 12 months.
Vogt said that IBM is trading at over three turns above its trailing three and five-year averages. According to the analyst, the shares are also pricing in 2022 and 2023 earnings estimates that are 10% higher than his forecast.